Suppression of B7-H7 Enhanced MCF-7 Cancer Cell Line’s Chemosensitivity to Paclitaxel
Authors:
- 25 April 2024
- journal article
- research article
- Published by Springer Nature in Molecular Biotechnology
- Vol. 67 (4) , 1597-1605
Abstract
The B7-H7 is the newest addition to the B7 family of proteins that is present in the majority of malignancies. In this respect, the goal of the work was to investigate the impact of B7-H7 inhibition on breast cancer cells when paclitaxel and small interference RNA (siRNA) were combined. B7-H7 siRNA was used with Paclitaxel to treat MCF-7 cells. The IC50 of Paclitaxel and the cell survival was then assessed through using MTT assay. Investigation was conducted using flow cytometry to both the induction of apoptosis and the cell cycle. In addition, the clonogenic capacity of MCF-7 cells was investigated. Furthermore, qRT-PCR, was used to evaluate expression of genes. Our results demonstrated that suppressing B7-H7 sensitizes MCF-7 cells to Paclitaxel by triggering apoptosis and altering the expression of critical apoptosis mediator genes. In addition, the cell cycle was stopped in the sub-G1 and also G2-M phases as a result of the combination therapy leading prevention of developing colonies by MCF-7 cells. B7-H7 silencing improved the chemosensitivity of MCF-7 cells to Paclitaxel and demonstrated antiproliferative effects. After the adequate study has been conducted, this strategy may be regarded as a possible alternative treatment option for this cancer.Keywords
This publication has 30 references indexed in Scilit:
- Micro RNA-34a sensitizes MCF-7 breast cancer cells to carboplatin through the apoptosis inductionGene Reports, 2021
- Information needs on breast cancer genetic and non-genetic risk factors in relatives of women with a BRCA1/2 or PALB2 pathogenic variantThe Breast, 2021
- HHLA2 deficiency inhibits non‐small cell lung cancer progression and THP‐1 macrophage M2 polarizationCancer Medicine, 2021
- Gallic acid potentiates the apoptotic effect of paclitaxel and carboplatin via overexpression of Bax and P53 on the MCF‐7 human breast cancer cell lineJournal of Biochemical and Molecular Toxicology, 2020
- Health and Racial Disparity in Breast Cancer2019
- HMGA2 and Bach‐1 cooperate to promote breast cancer cell malignancyJournal of Cellular Physiology, 2019
- Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart DataGeburtshilfe und Frauenheilkunde, 2018
- The Summit for Cancer Immunotherapy (Summit4CI), June 26–29, 2016 Halifax, CanadaCancer Immunology, Immunotherapy, 2017
- Breast cancer incidence by estrogen receptor status in Denmark from 1996 to 2007Breast Cancer Research and Treatment, 2012
- Paclitaxel-induced apoptosis in MCF-7 breast-cancer cellsInternational Journal of Cancer, 1997